A.O.U. di Modena - Policlinico

Modena, Emilia-Romagna 41124

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Transitional Cell, Neoplasms, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed